LENZ Therapeutics, Inc. (LENZ) Media https://ir.lenz-tx.com/news-events/media/rss en-us https://d1io3yog0oux5.cloudfront.net/_8635510463fa1e52d68f761be7047ea9/lenztx/files/theme/images/logo-sm.png LENZ Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[LENZ Therapeutics - NASDAQ Bell Ring]]> https://vimeo.com/1005870848/25ff8ecdc5?share=copy Fri, 30 Aug 24 00:00:00 -0400 https://vimeo.com/1005870848/25ff8ecdc5?share=copy <![CDATA[We Await the Fate of a New Presbyopia Drop - Significant Findings]]> https://modernod.com/significant-findings/we-await-the-fate-of-a-new-presbyopia-drop Mon, 19 Aug 24 00:00:00 -0400 https://modernod.com/significant-findings/we-await-the-fate-of-a-new-presbyopia-drop <![CDATA[Lenz Therapeutics Submits NDA for Presbyopia Eye Drop]]> https://eyewire.news/tv/lenz-therapeutics-submits-nda-for-presbyopia-eye-drop Wed, 14 Aug 24 00:00:00 -0400 https://eyewire.news/tv/lenz-therapeutics-submits-nda-for-presbyopia-eye-drop <![CDATA[Aceclidine, a Pupil-Selective Miotic, Demonstrates Positive Topline Data in Phase 3 Presbyopia Trials]]> https://digital.presbyopiaphysician.com/publication/?m=66575&amp;i=822958&amp;p=8&amp;ver=html5 Tue, 04 Jun 24 00:00:00 -0400 https://digital.presbyopiaphysician.com/publication/?m=66575&amp;i=822958&amp;p=8&amp;ver=html5